Champions Oncology, Inc.: updates and filings

CSBRNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$4.59

November 17, 2026Market cap $64M

What Ploutos Investor adds for Champions Oncology

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from FY2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 23 daysAround Dec 11, 2026 · for Q2 2027

last Sep 10, 2026next Dec 11, 2026

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Jul 27, 2026 latest annualSep 11, 2026 latest quarterly
  • Oct 16, 2026Shareholder vote
    Form8-K
  • Sep 11, 2026Quarterly reportfor the period to Jul 31, 2026
    Form10-Q
  • Sep 10, 2026Results of operations
    Form8-K
  • Aug 28, 2026Additional annual meeting material
    FormDEFA14A
  • Aug 28, 2026Annual meeting proxy statement
    FormDEF 14A
  • Jul 27, 2026Annual reportfor the period to Apr 30, 2026
    Form10-K
  • Jul 27, 2026Results of operations
    Form8-K
  • Mar 30, 2026Officer or director change
    Form8-K
  • Mar 12, 2026Quarterly reportfor the period to Jan 31, 2026
    Form10-Q
  • Mar 12, 2026Results of operations
    Form8-K
  • Dec 15, 2025Quarterly reportfor the period to Oct 31, 2025
    Form10-Q
  • Dec 15, 2025Results of operations
    Form8-K
  • Oct 16, 2025Shareholder vote
    Form8-K
  • Sep 15, 2025Quarterly reportfor the period to Jul 31, 2025
    Form10-Q
  • Sep 15, 2025Results of operations
    Form8-K
  • Aug 22, 2025Additional annual meeting material
    FormDEFA14A
  • Aug 22, 2025Annual meeting proxy statement
    FormDEF 14A
  • Jul 23, 2025Annual reportfor the period to Apr 30, 2025
    Form10-K
  • Jul 23, 2025Results of operations
    Form8-K
  • Jul 21, 2025Financial statements and exhibits
    Form8-K
  • Mar 17, 2025Quarterly reportfor the period to Jan 31, 2025
    Form10-Q
  • Mar 11, 2025Results of operations
    Form8-K
  • Mar 4, 2025Letter from the SEC
    FormUPLOAD
  • Mar 3, 2025Correspondence with the SEC
    FormCORRESP
  • Feb 26, 2025Letter from the SEC
    FormUPLOAD

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 13, 1995.

The full analysis

What do Champions Oncology's filings show?

The filings are where every one of Champions Oncology's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.